@article {65,
	title = {Capitalizing on Insights from Human Genetics to Identify Novel Therapeutic Targets for Coronary Artery Disease.},
	journal = {Annu Rev Med},
	volume = {70},
	year = {2019},
	month = {2019 01 27},
	pages = {19-32},
	abstract = {<p>Coronary artery disease (CAD) is a major cause of morbidity and mortality. Unfortunately, despite decades of research focused on disease pathogenesis, we still lack a sufficient pharmacopeia for preventing CAD. The failure of many novel cardiovascular drugs to improve clinical outcomes reflects the major substantial challenge of drug development: identifying causal mechanisms that can be therapeutically manipulated to lower disease risk. Identifying genetic variants that are associated with risk of CAD has emerged as a clear path toward improving our understanding of the underlying mechanisms that lead to disease and to the development of new therapies. Here, we review the potential utility and limitations of using human genetics to guide the identification of therapeutic targets for CAD.</p>},
	issn = {1545-326X},
	doi = {10.1146/annurev-med-041717-085853},
	author = {Young, Erica P and Stitziel, Nathan O}
}
